K. Bobby Chao
Jack J. Florio
Johnson YN Lau
Judy D. Olian
J. Stephen Pollock
Micheal Austin | VP, BYD America
Micheal Austin received his undergraduate in Design Engineering and completed a Masters Degree in Mechanical Engineering from BYU in 1992. He began his career at Motorola where he served for 15 years. While there, he served as the senior ODM director for the Mobile Devices business unit responsible for over 60M phone purchases annually. His procurement experience also included serving as the Global Energy Commodity Manager for Motorola. While an Engineering Manager, he was selected as one of Motorola's Distinguished Innovators (with 22 US patents). He has considerable Asian international business experience which proves invaluable in his role as Vice President at BYD America. BYD is a $4B Chinese company listed on the Hong Kong exchange (HK1211) and has over 140,000 employees. Recently, Warren Buffett purchased 10% stake in BYD and placed David Sokol on the BYD board, joining Austin as only the second Caucasian in the company.
Sage Brennan | Co-founder, MobileMonday Shanghai
Sage Brennan is an independent media and Internet analyst, most recently based in Shanghai, China. Brennan has a broad range of marketing, consumer research, market entry and fi nancial analysis experience in China, as both an advisor and a manager of entrepreneurial companies. Brennan is a founder and organizer of the Shanghai chapter of the global MobileMonday movement, one of the most active chapters of over 50 around the world with over 3,000 participants. He also runs Mountain View Vintners, a negociant winemaking company in northern California that has distributed fine wine around the world since 1978.
Brennan was recently research director of Hong Kong-based hedge fund Pacific Sun Investment Management and chief representative of the firm's China operations, based in Shanghai. He was earlier generalmanager of Shanghai-based Pacific Epoch, a boutique telecom andtechnology research fi rm that was acquired by JL McGregor & Co. in 2006. He contributed the weekly "This Week in China" column to Dow Jones' MarketWatch for two years, and remains a frequent commentator on China-related media and technology issues in print media and on programs such as CNBC's ‘Asia Squawk Box.' Brennan also spent two years at a technology research fi rm in Beijing, where he advised on strategic approaches to investing in China. His early career included sales and marketing roles at Nextel Communications and at several venture capital-backed technology fi rms in Silicon Valley.
A native of Boston, Brennan holds both an MBA and an undergraduate degree in International Studies from the University of North Carolina at Chapel Hill, and has been speaking and studying Mandarin since he first lived in Beijing in 1987.
K. Bobby Chao | Founding Managing Director at DFJ DragonFund China
Mr Chao has tremendous experience in technology‐focused venture in China and internationally. In 2005, as a partner, Mr. Chao organized and founded DFJ DragonFund, a leading venture capital firm in the People's Republic of China.
Mr. Chao was born in China and spent his professional career in the U. S. and Asia. He began his career as one of the original founders of Cadence Design Systems and, was Cadence's Vice President and GM of Asia, responsible for sales, marketing and operations in Asia and Japan. After Cadence, he founded and served as chairman and CEO of OCRON, a pioneer in the optical character recognition and document management space, until an acquisition by Umax Group in 1993. During his tenure with Umax, Mr. Chao was responsible for corporate investment and marketing. He later incubated and served as Chairman and CEO of VA Linux (LNUX). Subsequently, he was an early investor in AboveNet (ABVT), Oplink (OPLK), Omnivision (OVTI) and NetScreen (JNPR). Mr. Chao is currently serving as the chairman and board director of several China and U.S.-based companies.
Mr. Chao holds MS in Physics and Aeronautical Engineering from Georgia State University and Stanford University respectively.
Eddie Chen '04 | CEO, THQ*ICE
Eddie Chen is the CFO and co-founder of ICE Entertainment, an online game developer and operator based in Shanghai, China. He also serves as the CEO of THQ*ICE, a joint venture between ICE and THQ, one of the World's leading video game publisher. As the CFO of the company, Mr. Chen led ICE's multiple rounds of equity and debt financing. Mr. Chen is also responsible for formulating the company's strategic objectives and establishing critical strategic alliances for ICE.
Following the formation of THQ*ICE, Mr. Chen relocated back to Los Angeles to look after the joint venture, focusing on building out the company's online game operations platform for North America. Prior to ICE, Mr. Chen was a member of American International Group's strategic planning and management consulting group, where he assisted AIG's Chairman of China in realigning the company's China strategies across insurance, investment management, banking, real estate and consumer finance. Before AIG, Mr. Chen was a management consultant with Accenture and later A. T. Kearney.
Mr. Chen received his MBA from UCLA Anderson School of Management, after graduating from Fudan University with a Bachelor's Degree in Economics. Mr. Chen is a CFA Charterholder.
Richard Colback '01 | Founder and President, Epic States
Richard is the Founder and President of Epic States, a business intelligence, strategy and monitoring consultancy focusing on the use of social media, web 2.0 and 3.0 technologies for businesses. Epic States is based in Los Angeles, with additional offices in San Diego and Orange County. Current client focus is in the Entertainment, Sports, Healthcare, and Financial services industries.
Richard is a frequent speaker on the use of engagement technologies by businesses, and provides training and advisory support to executives within medium and large-scale businesses to enable them to manage the internal transition from traditional to new media marketing. His prior experience includes working as a strategic consultant with Bain and Company and Booker Tate in Africa, Europe and the Caribbean. He has also been involved in the start up and management several companies within the media, transportation and manufacturing industries.
He received his MBA from the Anderson Graduate School of Management at the University of California Los Angeles where he was a Fulbright Scholar, and is a graduate of the University of Southampton in the United Kingdom where has was an Engineering and Physical Sciences Research Scholar.
Linda Ding | Regional Manager - APAC, Laserfiche
Ms. Ding joined Laserfiche in 2007. As the Territory Manager for APAC, she is in charge of business and market development in the Asia-Pacific Rim.
Ms. Ding has been instrumental in conducting research and creating strategic business plans to promote training, channel development, and customer relationships resulting in an awareness of the benefits of enterprise and digital document technology into the greater China area.
Under her leadership, the Laserfiche product suite has been translated into simplified and traditional Chinese versions. To provide stronger local product services and training, Ms. Ding has also developed a professional Presales and Support team in Shanghai, which established the foundation to enable Laserfiche to become a full service Enterprise Content Management (ECM) solution provider for the greater China area.
Ms. Ding holds B.A. degrees in Economics and Cognitive Science from UC Berkeley and an M.A. degree in Program Evaluation from Claremont Graduate University. Her professional research interest focuses on how ECM technology facilitates communication across business units and impacts a sustainable innovative culture within bureaucratic organizational structures.
Jack J. Florio | Senior Vice President at Brinson Patrick Securities; Vice President of Marketing and Communications at San Diego Tech Coast Angels
Jack's is Senior Vice President with Brinson Patrick Securities Corporation, a New York based investment banking boutique serving the equity capital raising needs of small cap to Fortune 500 publicly traded companies. He is also Vice President, Marketing and Communications and an active Life Science investor with San Diego Tech Coast Angels, the largest angel investor network in the United States.
Previously Jack had a 30-year career with Eli Lilly and Company where he held a number of senior management positions in the US and abroad until 2001.
Jack arrived in San Diego in April 2001 and has taken on full and part time senior management roles in seven different biotech and medical device companies in the US, Europe, and China. This included EVP Corporate Development for Vital Therapies where he focused on China and the US related to commercialization and/or partnering plus support for clinical trials as well as capital acquisition. In this capacity he made over a dozen trips to 10 cities in China and visited numerous high tech / biotech parks, hospitals, and potential partners. Jack remains an advisor to HepaWash for their long term plans in China and the US.
Jack also is very active in the community in a variety of roles including working with CONNECT on Springboard panels and other programs as well as several BIOCOM and BayBio committees. Jack is currently on the boards of the San Diego Chapter of the American Liver Foundation and the San Diego Venture Group as well as Amplyx Pharmaceuticals and IYIA Technologies.
Terry Horsmon | Managing Partner, True North Strategies
Terry Horsmon is the Managing Partner of True North Strategies. He is a business leader and entrepreneur with 30 years of experience in global markets bringing products to market, hiring and training top level teams and generating profit for his clients and their investors.
Currently a China-based media executive, he has worked in every area of the entertainment industry, including music, film, television and digital platforms. Since 2004, Terry has been heavily involved in China's growing media and entertainment business, particularly in the growth of the internet. His successful projects include the launch of branded content company Footprint Worldwide, the development of both music and film projects with government Joint Venture CRC Jianian and the launch of Metan Development Group's Digital Content operation.
Terry has a deep grasp of how western companies need to approach China as a business opportunity. He currently is working with a large group of global brands to create new content for digital platforms n China, including the launch of Fuel TV and the creation of a new form of character-driven digital content in China.
As a marketing and project executive at Columbia Pictures, he was part of an executive team that launched over 100 films, including a dozen Oscar and Golden Globe winners. He led a team at Columbia Pictures that helped the company take the industry into breakthrough new media distribution platforms and technologies.
Trained as a management and strategy consultant at McKinsey & Co., he has worked with such global brands as BMW, Anheuser Busch, DreamWorks Animation, Accenture, EDS, General Motors and Hilton Hotels. Terry has AB degree (Magna Cum Laude) from Amherst College and he received his MBA from Harvard Business School. He did his post graduate study in Yale University Medical School.
Terry has been involved with the launch of 12 start-up companies, including 5 companies in China, where he spends 75% of his professional time.
Robert Hsu | President, Absolute Return Capital Advisors LLC; Editor, China Strategy
Robert Hsu is the founder and president of money management firm Absolute Return Capital
Advisors, LLC (ARCA). Prior to forming ARCA in 2004, Hsu was a hedge fund trader at Goldman
Sachs. Hsu is also the editor of two top rated investment newsletters China Strategy and Asia
Edge. In addition, he is the author of Amazon best-seller, China Fireworks: How to make dramatic wealth from the world's fastest growing economy. Hsu graduated from the University of California, Los Angeles, with a BA in economics. A recognized expert on investing in China, he has appeared on numerous financial television and radio shows around the world including CNBC and Bloomberg group, a turnaround management, restructuring and corporate advisory services firm.
Chris Keller '05 | Head of Strategic Business Development, Energy & Environmental Solutions, Applied Materials
Chris Keller has been the global head of strategic business development for the Energy & Environmental Solutions group at Applied Materials since October 2008. In his current role, he is responsible for exploring and securing outside sources of growth across the cleantech market place, with a focus on photovoltaics (PV), solid state lighting (SSL), and energy storage. Current projects include M&A transactions, venture investments, commercial partnerships, and some marketing and strategy activities.
Prior to his current role, Keller had been in the M&A group at Applied since July 2005. In that position, he led several transactions that launched Applied's entry into the solar equipment business, including Applied Films Corp ($464 million), HCT Shaping Systems SA ($478 million), and Baccini S.p.A ($331 million).
Keller also serves on the Environmental Commission for the city of Los Altos where he resides with his wife and four daughters.
Wei-Tai Kwok | Vice President of Marketing, Suntech Power
Wei-Tai joined Suntech America in May 2009 and has global responsibility for corporate marketing, product marketing, advertising and public relations.
Previously he spent 20 years in advertising and internet marketing, most recently at Molecular, a digital consultancy and wholly-owned subsidiary of Aegis Group PLC. Prior to Molecular, Wei-Tai was a Managing Director at Ion Global, a Chinadotcom ebusiness consultancy, and was also CEO of Dae Advertising, a full service Asian American advertising agency which he helped start in 1990.
Kwok has been interested in energy and environmental issues ever since early in his career when he worked for MHB Technical Associates, the Silicon Valley nuclear power consulting firm founded by three whistle-blowing engineers whose defection from GE Nuclear in 1976 galvanized anti-nuclear groups across the country. Recently, he helped to establish the nonprofit US-China Green Energy Council. He is also currently president of The 1990 Institute, a US-based, action oriented non-profit focused on poverty alleviation and environmental sustainability in China.
Originally from the Washington DC area, he lives in Lafayette, California, with his wife and two children. He received his B.A. in Economics and Political Science from Yale University, and also studied at Fudan University in Shanghai.
Dr. Lau has a varied background including academic medicine, financial management and executive management of pharmaceutical/biotech companies. Dr. Lau is currently Chairman of XenoBiotic Laboratories, XBL-China, Kinex Pharmaceuticals, SinoPhyto Solutions; serves on the Board of Chelsea Therapeutics; and serves as an advisor to a few other US and Asian companies.
Dr. Lau was previously Managing Director of Healthcare Investment Banking of Roth Capital Partners. Before that he was Chairman and CEO of Ribapharm Inc. where he led the second largest IPO in the biotechnology history. Prior to that he was Senior VP and Head of R&D at ICN Pharmaceuticals, was Senior Director of Antiviral Therapy at Schering-Plough. Prior, he was a member of the faculty of Gastroenterology, Hepatology, and Nutrition as well as Molecular Genetics and Microbiology at the University of Florida.
From the pharmaceutical side, Dr. Lau has been involved with a number of successful Investigational New Drugs (INDs) and New Drug Applications (NDAs), including drugs for the treatment of hepatitis, human immunodeficiency virus, immunologic diseases including rheumatoid arthritis, oncology, and diagnostics.
From the scientific side, Dr. Lau has published over 200 original scientific papers (with a H-score of 57), over 50 reviews and editorials in leading scientific journals, edited two books and has more than 10 patents. Dr. Lau was elected a Fellow of the Royal College of Physicians of the United Kingdom in 2004. Dr. Lau received his medical degree and doctoral degree from the University of Hong Kong. Dr. Lau is a trained hepatologist and liver transplant physician and is also an honorary professor in ophthalmology research. Dr. Lau has received many awards including the Hans Popper Liver Scholar.
Hanson Li | Executive Director, Hina Group
Prior to joining The Hina Group, Mr. Hanson Li gained significant operational experience at Capital One Financial, EqualFooting, and managing his own businesses. At Capital One, a Fortune 500 financial services company, he held management roles at AmericaOne, the company's telecom subsidiary. At EqualFooting, a B2B/software start-up focused on small businesses, he held dual Vice President roles managing both operations and strategy. Mr. Li also founded several businesses, including a coffeehouse/bar in Austin, Texas and a consulting practice that advised small businesses. Complimenting this operational background, Mr. Li was an associate at Mercer Management Consulting, advising on M&A for technology companies. He also worked at Cagan McAfee Capital Partners, a private equity firm focusing on technology and growth companies.
Mr. Li earned an MBA from the Stanford Graduate School of Business. He was named one of five Siebel Scholars and graduated as an Arjay Miller Scholar. He also holds a MA and BA degree from Stanford University.
Judy D. Olian | Dean and John E. Anderson Chair in Management at UCLA Anderson School of Management
Judy D. Olian, Ph.D., is the eighth dean of UCLA Anderson School of Management and is the John E. Anderson Chair in Management. She began her appointment on January 1, 2006 after serving five and a half years as dean and professor of management at the Smeal College of Business Administration at Pennsylvania State University.
Under her leadership, UCLA Anderson is executing a comprehensive strategic plan to expand the school's global presence and partnerships and is engaged in an aggressive growth campaign, which will result in hiring a record number of faculty from the world's best research institutions. The school is developing a global foot print with a series of targeted global partnerships, especially in China, India and Mexico. Since arriving at UCLA Anderson, the School celebrated the launch of the Laurence and Lori Fink Center for Finance and Investments, the newest of the School's six research centers. Dean Olian is expanding the School's Board of Visitors, attracting executives who bring diverse functional and global perspectives. The school is also in a significant campaign to assure its financial footing as one of only two public schools of management included routinely among the ranks of the leading schools of management in the world. Olian served as the chairman of the Association to Advance Collegiate Schools of Business (AACSB International), the premier business accrediting and management thought leadership organization in the world. She also has chaired two industry-wide AACSB commissions addressing the future of management education, and the looming crisis of shortages in business Ph.D. graduates.Olian has been widely published in journals on human resource management and business alignment of management systems, wrote a weekly syndicated newspaper column and hosted a monthly television show on current topics in business. She is a sought-after speaker and has consulted for major corporations. Olian's honors include the American Council on Education Fellowship and the Maryland Association for Higher Education Award for Innovation.
As dean of UCLA Anderson, Judy Olian leads a school that annually provides management education to more than 1,700 students enrolled in MBA, Executive MBA, Fully-Employed MBA and doctoral programs, and to more than 2,000 professional managers through executive education programs. The school has several widely recognized research centers and more than 35,000 alumni worldwide.Prior to her tenure at Smeal, she served as acting dean, senior associate dean and professor of management and organization at the Robert H. Smith School of Business at the University of Maryland.Born and raised in Australia, she holds a B.S. degree in Psychology from the Hebrew University, Jerusalem, and M.S. and Ph.D. degrees in Industrial Relations from the University of Wisconsin, Madison.
J Stephen Pollock '08 | Regional Sales Manager, Suntech
J. Stephen Pollock is Regional Sales Manager for Suntech America, the world's largest producer of crystalline silicon photovoltaic modules. Currently, Stephen manages the Suntech Residential and Commercial dealer network for the Southwest (Southern CA, NM, AZ and HI). Prior to working for Suntech, Stephen founded CollectiveSol, an online solar analysis, design and brokering company focused on residential solar installations throughout California. Other clean tech experience includes work for SunPower and Advanced Solar Electric, a solar power systems integrator. Stephen is also Executive Director of Sustech, a Southern California regional clean-tech learning and networking organization. Previous to receiving his MBA from UCLA Anderson School of Management, Stephen spent 6 years with Siemens AG in both corporate venture capital and business development roles and graduated from USC with a BS in Entrepreneurship.
Shaun Rein | Managing Director China Market Research Group (CMR) Shaun Rein is the Managing Director of CMR, the world's leading strategic market intelligence firm. He is one of the world's recognized thought leaders on strategy consulting.
He is a columnist for Forbes on Leadership, Marketing, and China and for BusinessWeek's Asia Insight section. He is often featured in the Wall Street Journal, the Harvard Business Review, The Economist, The Financial Times, Newsweek International, Bloomberg, Time, and the New York Times. He is regularly interviewed by American Public Radio's Marketplace and NPR. He frequently appears to deliver commentary on CNBC's Squawk Box, Bloomberg TV, CBS News, and CNN International TV.
Before founding CMR, he was the Chief of Research for venture capital firm Inter-Asia Venture Management. He also was the Managing Director, Country Head China for e-learning software company WebCT where he also ran the company's Taiwan and South Korean operations. He also served as the Assistant Director of the Centre for East Asian Research at McGill University.
He earned his Master's degree from Harvard University focused on China's economy and received a BA Honours from McGill University.
Allen Shen | Producer, KAZN-AM Radio, Los Angeles
Mr. Allen Shen is a renowned radio host and commentator working in the radio media (AM 1300 or KAZN). For the past 10 years he has been hosting a variety of programs with topics that touched upon US/Sino relationships.
Luomei Shu | Commercial Counselor, The Consulate General of the People's Republic of China in Los Angeles
Luomei Shu is based in Los Angeles since 2008 as Commercial Counselor in Consulate General of China in Los Angeles with the mission to promote bilateral trade and economic cooperation between China and the U.S. Prior to Los Angeles, she was working with Ministry of Commerce of China as Director for Sino-US Economic & Trade Relation and Director for Bilateral Economic and Trade Relations of Sino-Canadian, Sino-Australian, Sino-New Zealand and Sino-South Pacific Island Countries. She also worked as Commercial Consul in Consulate General of China in Los Angeles in 1999-2004 and Vice Commercial Consul in Consulate General of P.R.China in San Francisco in 1993-1996.
Luomei Shu graduated from University of International Business & Economics, Beijing and joined Ministry of Foreign Economic Relations and Trade, China in 1988.
Richard Soll | Senior Vice President of Integrated Services, WUXI AppTec
Dr. Richard M Soll is currently Senior Vice President, Integrated Services at WuXi AppTec. Previously he was the Chief Scientific Officer and Vice President, R&D at the San Diego based company TargeGen where he led innovative clinical-stage drug discovery and development programs for isoform-specific PI3K inhibitors as therapeutics for inflammation, respiratory disease and cancer, mutitargeted src/VEGF inhibitors as the first topical kinase inhibitors for age-related macular degeneration and highly selective JAK2 inhibitors for the treatment of myeloproliferative disorders. Dr. Soll was the Vice President of Chemistry at Ontogen and also founded the chemistry department at 3-Dimensional Pharmaceuticals where he served as Vice President, Chemistry.
Dr. Soll's drug discovery and development experiences span numerous clinical indications and cover a wide range of molecular targets including inhibitors of kinases, serine proteases, GPCRs and protein-protein interactions. Through his contributions more than 6 clinical compounds have entered the clinic for cardiovascular disease, cancer, and ocular indications.
Dr. Soll serves as a scientific advisory board member to biotech companies and advisor to investors.
Dr. Soll has extensively published in peer reviewed journals and is an inventor of numerous issued and pending patents.
Donald Straszheim | Senior Managing Director and head of China Research, International Strategy & Investment
Mr. Donald Straszheim is a Senior Managing Director and head of China Research. Don has been a long-time macro economist on Wall Street and, more recently, a China specialist.
Prior to joining ISI in 2009, Don operated his own China-focused economic consultancy, Straszheim Global Advisors. From 2006 to 2008 he was Vice Chairman of Roth Capital Partners in CA, spearheading its China Initiative. Before that, Don was President of the Milken Institute. Prior to that, Don served as global Chief Economist at Merrill Lynch in New York where he was an Institutional Investor's ranked economist for 10 consecutive years. Earlier he was Chief Economist at Wharton Econometrics, Chief Economist at Weyerhaeuser Company and U.S. Economist for IDS.
Don graduated from Purdue University in 1963 with a BS, received his MS and PhD, also from Purdue, in1967 and 1971, respectively.Xun Wang | President, Syngenta Biotechnology (China) Co. Ltd.
Xun Wang is the President of Syngenta Biotechnology (China) Co. Ltd. (SBC). He is also the Asia Pacific Regional Head of Biotech R&D in Syngenta (www.syngenta.com). Meanwhile, he serves as a member in the Syngenta R&D Leadership Council and the Syngenta Biotechnology Leadership Team. Returned to China in 2006 after 18 years in USA, he lead the effort of setting up SBC, the sixth Syngenta global R&D center, with company committed investment of over $100 million USD in the first five years. SBC was opened in October 2008 in Beijing. Currently with 70 research scientists, SBC is targeted to have 200 professionals by 2012 in its 25,000 m2 modern research facilities. SBC is the first foreign invested biotechnology center in China, was elected as a top "100 Fast Growing Company" by Business Watch in 2008 and 2009. In 2009, the China Rural Economy Press, a state-owned publisher under the Chinese Ministry of Agriculture, named Dr. Wang as one of the "10 Outstanding Entrepreneurs in Chinese Agriculture."
Prior to this, he held various positions in Syngenta, including Head of R&D in Syngenta China, Section Head of Trait Research and Technologies in Syngenta Biotechnology Inc. North Carolina USA, and Director at Torrey Mesa Research Institute, San Diego USA. Before Syngenta, he was a Research Manager in Pioneer Hi-Bred International, Iowa USA. During the last sixteen years, he led the first plant genomic project in agricultural industries, and managed Syngenta biotechnology R&D functions where a number of biotech products have been developed to the market.
Outside of work, he enjoys swimming, hiking and golfing. He received his Ph.D. in 1993 from Iowa State University and B.S. in 1986 from Jilin University, China.
Eric Wesoff | Senior Analyst, Greentech Media
Eric Wesoff is a senior analyst at Greentech Media (www.greentechmedia.com) where he covers the financing and technology of renewable energy and cleantech markets. His clients and networks include the leading investors and public and private companies in renewable energy.
Eric's expertise covers solar power, smart grid, fuel cells, biofuels and advanced batteries. His strengths are in market research and analysis, business development and due diligence for investors. He frequently consults for energy startups and Silicon Valley's premier venture capitalists.
Prior to joining Greentech Media, Eric Wesoff founded Sage Marketing Partners in 2000 to provide sales and marketing-consulting services to venture-capital firms and their portfolio companies in the alternative energy and telecommunications sectors. Mr. Wesoff has become a well-known, respected authority and speaker in these fields. He also was the publisher of the Venture Power newsletter, a subscription-only newsletter covering venture-capital investment in renewable energy. He has consulted for Merck, JDSU, Coherent, IBM and scores of other firms, governments and organizations.
Michael Woo | Dean, College of Environmental Design at Cal Poly Pomona
Michael Woo, the son of Wilbur K. Woo, is the Dean of the College of Environmental Design at Cal Poly Pomona. He was the first Asian American and the first trained urban planner elected to the Los Angeles City Council, on which he served eight years as a representative of Hollywood and surrounding neighborhoods. For the past five years, Woo has served as a Member of the Los Angeles City Planning Commission. He is chairman of the governing board of Hollywood Presbyterian Medical Center; chairman of the board of directors of Sustainable Economic Enterprises of Los Angeles, the nonprofit organization which runs the Hollywood Farmers Market; and board chairman of Smart Growth America, the national coalition advocating compact urban development and sustainable transportation alternatives. In the last five years, Woo has become increasingly interested in China's urbanization, traveling frequently to China to deliver lectures, organizing training programs for Shenzhen government officials, and co-teaching USC's Beijing Lab for urban planning graduate students.
Liu Yang | Assistant Professor, UCLA Anderson School of Management
Liu Yang is an assistant professor of finance at UCLA Anderson. Her research interests include theoretical and empirical corporate finance in the areas of mergers and acquisitions, corporate restructuring, corporate governance, and financial intermediation.
Liu received her PhD in Finance from University of Maryland her MS in both Economics and Statistics from University of Illinois. Prior to earning her doctorate, she worked as a Senior Financial Analyst in the structured finance group in Federal Home Loan Mortgage Corporation.
Cecelia Zhou '01 | Director of M&A Finance, Life Technologies
Ms. Cecelia Zhou is the head of the M&A finance group at Life Technologies, a $9 billion public company in the life science and biotechnology space. Ms. Zhou leads a team of finance professionals contributing to executing the right acquisition strategy for the Company. She also leads the Financial Planning & Analysis function for the newly created diagnostics division of the Company. She has significant commercial operations experience leading the Asia Pacific Pricing Group at Life Technologies, implementing pricing strategy and team in Japan, Greater China and Oceania.
Prior to Life Technologies, Cecelia spent six years with Lehman Brothers working in various locations including Hong Kong, New York and Los Angeles. Her work experiences included investment banking, capital markets and equity research. Her clients included large financial institutions and sovereign banks in Asia Pacific, global conglomerates such as GE and Tyco, and high tech companies in the Silicon Valley.
Cecelia holds an MBA from the Anderson School of Business at UCLA, and BA of Economics and East Asian Studies from Wesleyan University in Connecticut. She is fluent in English, Chinese and Japanese, and has traveled extensively in Asia.
Xiaoming Zou | Director of External Drug Discovery, GSK
Xiaoming Zou is currently Director of External Drug Discovery for GSK's Immuno-Inflammation Center of Excellence of Drug Discovery with responsibility in identifying, establishing and managing external partnerships. Prior to GSK, he was a member of Amgen's outreach team from 2005 to 2009, as Senior Manager, Licensing and subsequently Director, External R&D Affairs. He had worked on sourcing, evaluating and executing of licensing deals in inflammation, cardiovascular, and neuroscience therapeutic areas. His key deals include Amgen's licensing of Kyowa Hakko's anti-CCR4 mAb program with $100 million upfront payment and Amgen's $290 million acquisition of Avidia. From 2001 to 2005, Xiaoming was Scientist & Senior Scientist with Amgen's Inflammation Research Therapeutic Area. He led several early stage drug discovery programs in both biologic and small molecule space. Xiaoming started his industry career as a post-doctoral fellow with Merck Research Laboratories from 1999 to 2001. Xiaoming was trained as an immunologist and holds Ph.D. from Columbia University, M.S. and B.S. from Tsinghua University..